167 related articles for article (PubMed ID: 1425310)
1. [Organ-preserving therapy of muscle-invasive bladder carcinoma].
Hartung R; Block T
Dtsch Med Wochenschr; 1992 Nov; 117(47):1818. PubMed ID: 1425310
[No Abstract] [Full Text] [Related]
2. When and how to treat superficial and muscle-invasive bladder cancer.
Zlotta AR
Eur Urol; 2007 Dec; 52(6):1554-7. PubMed ID: 17904728
[No Abstract] [Full Text] [Related]
3. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
Fernando SA; Sandler HM
Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
[TBL] [Abstract][Full Text] [Related]
4. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
5. Organ-sparing strategies in the management of invasive bladder cancer.
Yafi FA; Cury FL; Kassouf W
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
[TBL] [Abstract][Full Text] [Related]
6. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy for the treatment of muscle-invasive bladder cancer.
Thurman SA; DeWeese TL
Semin Urol Oncol; 2000 Nov; 18(4):313-22. PubMed ID: 11101096
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer--contemporary dilemmas in its management.
Whelan P
Eur Urol; 2008 Jan; 53(1):24-6. PubMed ID: 17889428
[No Abstract] [Full Text] [Related]
9. [Results of the multidisciplinary treatment of invasive bladder cancer].
Miyakawa M; Oishi K; Okada Y; Takeuchi H; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1931-9. PubMed ID: 3825830
[TBL] [Abstract][Full Text] [Related]
10. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
11. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
Merseburger AS; Kuczyk MA
Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
[TBL] [Abstract][Full Text] [Related]
12. [Infiltrating transitional carcinoma of the bladder (4). Our approach to stage pT2 and critique of other risk factors. Multifactorial analysis].
Escudero Barrilero A; Perales L; Romero J; Rodríguez Luna JM; Vallejo J; Rivas JA
Actas Urol Esp; 1991; 15(5):411-20. PubMed ID: 1807119
[TBL] [Abstract][Full Text] [Related]
13. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
14. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.
Scher HI
J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114
[No Abstract] [Full Text] [Related]
15. [Combined therapy for patients with invasive bladder cancer].
Startsev VIu; Karelin MI
Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212
[TBL] [Abstract][Full Text] [Related]
16. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
Heidenreich A
Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
[No Abstract] [Full Text] [Related]
17. Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23.
Herr HW
Eur Urol; 2008 Jul; 54(1):23-4. PubMed ID: 18262335
[No Abstract] [Full Text] [Related]
18. [The role of preserving therapy of invasive cancer of the urinary bladder].
Matveev BP; Sallum SD; Kamolov BSh; Figurin KM; Matveev VB; Volkova MI
Urologiia; 2005; (6):3-6. PubMed ID: 16419470
[TBL] [Abstract][Full Text] [Related]
19. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
Parekh DJ; Bochner BH; Dalbagni G
J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]